Barcelona, Spain — The luminous city of Barcelona became a beacon of hope and innovation in the realm of oncology as CanceRNA, an illustrious global consortium, held its 2nd Annual Meeting on September 4-5, 2023, at the Center of Genomic Regulation (CRG). Unveiling recent breakthroughs and future potentials in RNA-based cancer immunotherapies, the meeting became a crucible for fostering innovative ideas and forging future collaborations.
Exploring and extrapolating upon the latest advancements in personalized cancer vaccines, computational discoveries, and neoepitope identification, among other paramount topics, the assembly served as a pivotal platform to chart the course toward future innovations in cancer therapy and research.
A Symphony of Gratitude and Acknowledgment
Profound thanks are extended to Prof. Juan Valcárcel, Deputy Director of the CRG and Chair of its Gene Regulation, Stem Cells, and Cancer Department, whose gracious hospitality and esteemed expertise significantly amplified the event’s impact. Prof. Valcárcel’s unwavering support and constructive environment have undoubtedly sown seeds of future collaborative triumphs in the field.
In addition, heartfelt appreciation goes out to every partner and participant who enriched the discussions and collaborative spirit of the meeting: Prof.Michal Lotem, Amalia Herszkowicz, Rotem Karni, Erez Levanon, Efi Rahamim, Pablo Menendez, Narcís Fernández, and many more whose names echo in the corridors of breakthrough and innovation in cancer research.
Fostering Global Collaborations in the Pursuit of Healing
Backed by a formidable alliance of global institutions and organizations, including:
Hadassah Cancer Research Institute, The Hebrew University of Jerusalem, Bar-Ilan University, Center for Genomic Regulation (CRG), GSAP, Immunyx, Instituto de Medicina Molecular, Josep Carreras, University of Antwerp, Amsterdam UMC, Univer sitätsklinikumErlangen, Merck and InterLabs
The CanceRNA consortium perpetuates its commitment to melding wisdom, resources, and expertise, with a collective vision aimed at heralding a new era in RNA-based cancer therapies. This 2nd Annual Meeting not only celebrated the synergies of scientific intellect but also paved the way for future collaborations, catalyzing next-level breakthroughs in oncology.
For continual updates and insights into CanceRNA’s revolutionary endeavors and research breakthroughs, visit the CanceRNA Website and join us in our persistent journey toward redefining the landscape of cancer treatment.
